Skip to main content

Table 2 Logistic regression models examining utilization over 12 months post index among patients with a restrictive eating disorder (n = 4101)

From: Adolescent utilization of eating disorder higher level of care: roles of family-based treatment adherence and demographic factors

 

Outpatient

Outpatient—medical only

Outpatient—psychiatry only

Higher levels of care (HLOC)

HLOC—hospitalization

HLOC—higher level of psychiatry

aOR (95% CI)

p value

aOR (95% CI)

p value

aOR (95% CI)

p value

aOR(95% CI)

p value

aOR (95% CI)

p value

aOR (95% CI)

p value

Intercept

1.79 (1.00–3.20)

0.050

2.55 (1.46–4.44)

0.001

0.58 (0.33–0.99)

0.047

1.52 (0.54–4.28)

0.432

3.30 (0.86–12.67)

0.082

0.53 (0.15–1.81)

0.310

Medical center with high adherence to FBT (vs. low adherence)

0.96 (0.83–1.10)

0.541

1.04 (0.91–1.19)

0.542

1.02 (0.89–1.16)

0.805

0.94 (0.75–1.17)

0.563

0.84 (0.63–1.12)

0.237

0.88 (0.68–1.13)

0.315

Female (vs. male)

1.80 (1.53–2.12)

< .001

1.59 (1.36–1.86)

< .001

1.70 (1.45–1.98)

< .001

1.74 (1.29–2.34)

< .001

1.68 (1.15–2.44)

0.007

1.59 (1.12–2.27)

0.009

Age at index

1.07 (1.04–1.10)

< .001

1.05 (1.02–1.08)

0.001

1.01 (0.99–1.04)

0.343

0.97 (0.93–1.02)

0.261

0.94 (0.89–1.00)

0.055

0.98 (0.93–1.04)

0.522

Race/ethnicity (ref: white)

 Asian

0.74 (0.59–0.94)

0.014

0.97 (0.78–1.21)

0.786

0.70 (0.57–0.87)

0.001

0.72 (0.50–1.02)

0.068

0.83 (0.53–1.29)

0.407

0.79 (0.52–1.19)

0.255

 Black

0.58 (0.41–0.84)

0.003

0.71 (0.50–1.02)

0.061

0.53 (0.37–0.76)

< .001

0.54 (0.25–1.18)

0.122

0.72 (0.29–1.83)

0.495

0.34 (0.11–1.10)

0.071

 Hispanic, any race

0.78 (0.66–0.93)

0.006

0.96 (0.82–1.13)

0.623

0.72 (0.62–0.85)

< .001

0.66 (0.49–0.88)

0.005

0.74 (0.51–1.08)

0.117

0.67 (0.48–0.95)

0.024

 Othera

0.86 (0.69–1.08)

0.200

0.93 (0.76–1.14)

0.511

0.81 (0.67–0.99)

0.040

0.96 (0.69–1.32)

0.782

0.72 (0.45–1.15)

0.166

1.04 (0.72–1.51)

0.835

%mBMI at index

0.99 (0.99–0.99)

< .001

0.99 (0.98–0.99)

< .001

1.00 (0.99–1.00)

0.130

0.97 (0.97–0.98)

< .001

0.97 (0.96–0.98)

< .001

0.98 (0.97–0.99)

< .001

Diagnoses in year prior to inde

 Mood

0.94 (0.79–1.11)

0.457

0.69 (0.59–0.80)

< .001

1.41 (1.21–1.64)

< .001

0.68 (0.51–0.91)

0.009

0.41 (0.27–0.65)

< .001

0.83 (0.60–1.15)

0.262

 Anxiety

1.20 (0.86–1.69)

0.281

0.95 (0.71–1.27)

0.717

1.40 (1.05–1.87)

0.023

0.99 (0.61–1.61)

0.964

0.74 (0.34–1.62)

0.446

1.19 (0.71–2.00)

0.515

 Substance use

0.63 (0.45–0.90)

0.010

0.62 (0.45–0.86)

0.004

0.77 (0.55–1.07)

0.116

1.04 (0.60–1.81)

0.886

1.18 (0.54–2.57)

0.670

1.04 (0.57–1.92)

0.893

 Suicidality

1.04 (0.75–1.43)

0.832

1.21 (0.90–1.62)

0.199

0.80 (0.60–1.06)

0.125

1.91 (1.19–3.07)

0.007

1.75 (0.82–3.75)

0.150

2.25 (1.36–3.71)

0.002

 Medicare

0.98 (0.81–1.19)

0.848

1.14 (0.95–1.36)

0.154

0.79 (0.66–0.94)

0.008

0.87 (0.63–1.21)

0.408

1.02 (0.68–1.55)

0.908

0.69 (0.46–1.05)

0.083

  1. aOther race was created due to small n's and includes Native American/Alaskan Native, Native Hawaiian/Pacific Islander, Multiracial and Unknown race; %mBMI percent median body mass index, aOR adjusted odds ratio, 95% CI 95% confidence interval